[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antibiotics for Dogs and Cats Market Growth 2022-2028

December 2022 | 113 pages | ID: G0CE84EE5939EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

The global market for Antibiotics for Dogs and Cats is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Antibiotics for Dogs and Cats market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Antibiotics for Dogs and Cats market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Antibiotics for Dogs and Cats market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Antibiotics for Dogs and Cats market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Antibiotics for Dogs and Cats players cover Huvepharma, Merck & Co, Ceva Animal Health, Zoetis and Crystal Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage

This latest report provides a deep insight into the global Antibiotics for Dogs and Cats market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Antibiotics for Dogs and Cats market, with both quantitative and qualitative data, to help readers understand how the Antibiotics for Dogs and Cats market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

Market Segmentation:

The study segments the Antibiotics for Dogs and Cats market and forecasts the market size by Type (Tetracyclines, Penicillins and Sulfonamides), by Application (Cats and Dogs.), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
  • Tetracyclines
  • Penicillins
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Cephalosporins
  • Others
Segmentation by application
  • Cats
  • Dogs
Segmentation by region
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
Major companies covered
  • Huvepharma
  • Merck & Co
  • Ceva Animal Health
  • Zoetis
  • Crystal Pharma
  • Afrivet
  • Elanco
  • Merck Animal Health
  • Merial
  • Bayer Animal Health
  • Virbac
  • Ceva
  • Boehringer Ingelheim
  • Vetoquinol
  • Phibro Animal Health
  • NCPC
  • LKPC
Chapter Introduction

Chapter 1: Scope of Antibiotics for Dogs and Cats, Research Methodology, etc.

Chapter 2: Executive Summary, global Antibiotics for Dogs and Cats market size (sales and revenue) and CAGR, Antibiotics for Dogs and Cats market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.

Chapter 3: Antibiotics for Dogs and Cats sales, revenue, average price, global market share, and industry ranking by company, 2017-2022

Chapter 4: Global Antibiotics for Dogs and Cats sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.

Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.

Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace

Chapter 10: Manufacturing cost structure analysis

Chapter 11: Sales channel, distributors, and customers

Chapter 12: Global Antibiotics for Dogs and Cats market size forecast by region, by country, by type, and application.

Chapter 13: Comprehensive company profiles of the leading players, including Huvepharma, Merck & Co, Ceva Animal Health, Zoetis, Crystal Pharma, Afrivet, Elanco, Merck Animal Health and Merial, etc.

Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Antibiotics for Dogs and Cats Annual Sales 2017-2028
  2.1.2 World Current & Future Analysis for Antibiotics for Dogs and Cats by Geographic Region, 2017, 2022 & 2028
  2.1.3 World Current & Future Analysis for Antibiotics for Dogs and Cats by Country/Region, 2017, 2022 & 2028
2.2 Antibiotics for Dogs and Cats Segment by Type
  2.2.1 Tetracyclines
  2.2.2 Penicillins
  2.2.3 Sulfonamides
  2.2.4 Macrolides
  2.2.5 Aminoglycosides
  2.2.6 Cephalosporins
  2.2.7 Others
2.3 Antibiotics for Dogs and Cats Sales by Type
  2.3.1 Global Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
  2.3.2 Global Antibiotics for Dogs and Cats Revenue and Market Share by Type (2017-2022)
  2.3.3 Global Antibiotics for Dogs and Cats Sale Price by Type (2017-2022)
2.4 Antibiotics for Dogs and Cats Segment by Application
  2.4.1 Cats
  2.4.2 Dogs
2.5 Antibiotics for Dogs and Cats Sales by Application
  2.5.1 Global Antibiotics for Dogs and Cats Sale Market Share by Application (2017-2022)
  2.5.2 Global Antibiotics for Dogs and Cats Revenue and Market Share by Application (2017-2022)
  2.5.3 Global Antibiotics for Dogs and Cats Sale Price by Application (2017-2022)

3 GLOBAL ANTIBIOTICS FOR DOGS AND CATS BY COMPANY

3.1 Global Antibiotics for Dogs and Cats Breakdown Data by Company
  3.1.1 Global Antibiotics for Dogs and Cats Annual Sales by Company (2020-2022)
  3.1.2 Global Antibiotics for Dogs and Cats Sales Market Share by Company (2020-2022)
3.2 Global Antibiotics for Dogs and Cats Annual Revenue by Company (2020-2022)
  3.2.1 Global Antibiotics for Dogs and Cats Revenue by Company (2020-2022)
  3.2.2 Global Antibiotics for Dogs and Cats Revenue Market Share by Company (2020-2022)
3.3 Global Antibiotics for Dogs and Cats Sale Price by Company
3.4 Key Manufacturers Antibiotics for Dogs and Cats Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Antibiotics for Dogs and Cats Product Location Distribution
  3.4.2 Players Antibiotics for Dogs and Cats Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANTIBIOTICS FOR DOGS AND CATS BY GEOGRAPHIC REGION

4.1 World Historic Antibiotics for Dogs and Cats Market Size by Geographic Region (2017-2022)
  4.1.1 Global Antibiotics for Dogs and Cats Annual Sales by Geographic Region (2017-2022)
  4.1.2 Global Antibiotics for Dogs and Cats Annual Revenue by Geographic Region
4.2 World Historic Antibiotics for Dogs and Cats Market Size by Country/Region (2017-2022)
  4.2.1 Global Antibiotics for Dogs and Cats Annual Sales by Country/Region (2017-2022)
  4.2.2 Global Antibiotics for Dogs and Cats Annual Revenue by Country/Region
4.3 Americas Antibiotics for Dogs and Cats Sales Growth
4.4 APAC Antibiotics for Dogs and Cats Sales Growth
4.5 Europe Antibiotics for Dogs and Cats Sales Growth
4.6 Middle East & Africa Antibiotics for Dogs and Cats Sales Growth

5 AMERICAS

5.1 Americas Antibiotics for Dogs and Cats Sales by Country
  5.1.1 Americas Antibiotics for Dogs and Cats Sales by Country (2017-2022)
  5.1.2 Americas Antibiotics for Dogs and Cats Revenue by Country (2017-2022)
5.2 Americas Antibiotics for Dogs and Cats Sales by Type
5.3 Americas Antibiotics for Dogs and Cats Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Antibiotics for Dogs and Cats Sales by Region
  6.1.1 APAC Antibiotics for Dogs and Cats Sales by Region (2017-2022)
  6.1.2 APAC Antibiotics for Dogs and Cats Revenue by Region (2017-2022)
6.2 APAC Antibiotics for Dogs and Cats Sales by Type
6.3 APAC Antibiotics for Dogs and Cats Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Antibiotics for Dogs and Cats by Country
  7.1.1 Europe Antibiotics for Dogs and Cats Sales by Country (2017-2022)
  7.1.2 Europe Antibiotics for Dogs and Cats Revenue by Country (2017-2022)
7.2 Europe Antibiotics for Dogs and Cats Sales by Type
7.3 Europe Antibiotics for Dogs and Cats Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Antibiotics for Dogs and Cats by Country
  8.1.1 Middle East & Africa Antibiotics for Dogs and Cats Sales by Country (2017-2022)
  8.1.2 Middle East & Africa Antibiotics for Dogs and Cats Revenue by Country (2017-2022)
8.2 Middle East & Africa Antibiotics for Dogs and Cats Sales by Type
8.3 Middle East & Africa Antibiotics for Dogs and Cats Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Antibiotics for Dogs and Cats
10.3 Manufacturing Process Analysis of Antibiotics for Dogs and Cats
10.4 Industry Chain Structure of Antibiotics for Dogs and Cats

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Antibiotics for Dogs and Cats Distributors
11.3 Antibiotics for Dogs and Cats Customer

12 WORLD FORECAST REVIEW FOR ANTIBIOTICS FOR DOGS AND CATS BY GEOGRAPHIC REGION

12.1 Global Antibiotics for Dogs and Cats Market Size Forecast by Region
  12.1.1 Global Antibiotics for Dogs and Cats Forecast by Region (2023-2028)
  12.1.2 Global Antibiotics for Dogs and Cats Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Antibiotics for Dogs and Cats Forecast by Type
12.7 Global Antibiotics for Dogs and Cats Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 Huvepharma
  13.1.1 Huvepharma Company Information
  13.1.2 Huvepharma Antibiotics for Dogs and Cats Product Offered
  13.1.3 Huvepharma Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.1.4 Huvepharma Main Business Overview
  13.1.5 Huvepharma Latest Developments
13.2 Merck & Co
  13.2.1 Merck & Co Company Information
  13.2.2 Merck & Co Antibiotics for Dogs and Cats Product Offered
  13.2.3 Merck & Co Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.2.4 Merck & Co Main Business Overview
  13.2.5 Merck & Co Latest Developments
13.3 Ceva Animal Health
  13.3.1 Ceva Animal Health Company Information
  13.3.2 Ceva Animal Health Antibiotics for Dogs and Cats Product Offered
  13.3.3 Ceva Animal Health Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.3.4 Ceva Animal Health Main Business Overview
  13.3.5 Ceva Animal Health Latest Developments
13.4 Zoetis
  13.4.1 Zoetis Company Information
  13.4.2 Zoetis Antibiotics for Dogs and Cats Product Offered
  13.4.3 Zoetis Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.4.4 Zoetis Main Business Overview
  13.4.5 Zoetis Latest Developments
13.5 Crystal Pharma
  13.5.1 Crystal Pharma Company Information
  13.5.2 Crystal Pharma Antibiotics for Dogs and Cats Product Offered
  13.5.3 Crystal Pharma Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.5.4 Crystal Pharma Main Business Overview
  13.5.5 Crystal Pharma Latest Developments
13.6 Afrivet
  13.6.1 Afrivet Company Information
  13.6.2 Afrivet Antibiotics for Dogs and Cats Product Offered
  13.6.3 Afrivet Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.6.4 Afrivet Main Business Overview
  13.6.5 Afrivet Latest Developments
13.7 Elanco
  13.7.1 Elanco Company Information
  13.7.2 Elanco Antibiotics for Dogs and Cats Product Offered
  13.7.3 Elanco Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.7.4 Elanco Main Business Overview
  13.7.5 Elanco Latest Developments
13.8 Merck Animal Health
  13.8.1 Merck Animal Health Company Information
  13.8.2 Merck Animal Health Antibiotics for Dogs and Cats Product Offered
  13.8.3 Merck Animal Health Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.8.4 Merck Animal Health Main Business Overview
  13.8.5 Merck Animal Health Latest Developments
13.9 Merial
  13.9.1 Merial Company Information
  13.9.2 Merial Antibiotics for Dogs and Cats Product Offered
  13.9.3 Merial Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.9.4 Merial Main Business Overview
  13.9.5 Merial Latest Developments
13.10 Bayer Animal Health
  13.10.1 Bayer Animal Health Company Information
  13.10.2 Bayer Animal Health Antibiotics for Dogs and Cats Product Offered
  13.10.3 Bayer Animal Health Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.10.4 Bayer Animal Health Main Business Overview
  13.10.5 Bayer Animal Health Latest Developments
13.11 Virbac
  13.11.1 Virbac Company Information
  13.11.2 Virbac Antibiotics for Dogs and Cats Product Offered
  13.11.3 Virbac Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.11.4 Virbac Main Business Overview
  13.11.5 Virbac Latest Developments
13.12 Ceva
  13.12.1 Ceva Company Information
  13.12.2 Ceva Antibiotics for Dogs and Cats Product Offered
  13.12.3 Ceva Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.12.4 Ceva Main Business Overview
  13.12.5 Ceva Latest Developments
13.13 Boehringer Ingelheim
  13.13.1 Boehringer Ingelheim Company Information
  13.13.2 Boehringer Ingelheim Antibiotics for Dogs and Cats Product Offered
  13.13.3 Boehringer Ingelheim Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.13.4 Boehringer Ingelheim Main Business Overview
  13.13.5 Boehringer Ingelheim Latest Developments
13.14 Vetoquinol
  13.14.1 Vetoquinol Company Information
  13.14.2 Vetoquinol Antibiotics for Dogs and Cats Product Offered
  13.14.3 Vetoquinol Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.14.4 Vetoquinol Main Business Overview
  13.14.5 Vetoquinol Latest Developments
13.15 Phibro Animal Health
  13.15.1 Phibro Animal Health Company Information
  13.15.2 Phibro Animal Health Antibiotics for Dogs and Cats Product Offered
  13.15.3 Phibro Animal Health Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.15.4 Phibro Animal Health Main Business Overview
  13.15.5 Phibro Animal Health Latest Developments
13.16 NCPC
  13.16.1 NCPC Company Information
  13.16.2 NCPC Antibiotics for Dogs and Cats Product Offered
  13.16.3 NCPC Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.16.4 NCPC Main Business Overview
  13.16.5 NCPC Latest Developments
13.17 LKPC
  13.17.1 LKPC Company Information
  13.17.2 LKPC Antibiotics for Dogs and Cats Product Offered
  13.17.3 LKPC Antibiotics for Dogs and Cats Sales, Revenue, Price and Gross Margin (2020-2022)
  13.17.4 LKPC Main Business Overview
  13.17.5 LKPC Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Antibiotics for Dogs and Cats Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Antibiotics for Dogs and Cats Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tetracyclines
Table 4. Major Players of Penicillins
Table 5. Major Players of Sulfonamides
Table 6. Major Players of Macrolides
Table 7. Major Players of Aminoglycosides
Table 8. Major Players of Cephalosporins
Table 9. Major Players of Others
Table 10. Global Antibiotics for Dogs and Cats Sales by Type (2017-2022) & (K Units)
Table 11. Global Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
Table 12. Global Antibiotics for Dogs and Cats Revenue by Type (2017-2022) & ($ million)
Table 13. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2017-2022)
Table 14. Global Antibiotics for Dogs and Cats Sale Price by Type (2017-2022) & (US$/Unit)
Table 15. Global Antibiotics for Dogs and Cats Sales by Application (2017-2022) & (K Units)
Table 16. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Table 17. Global Antibiotics for Dogs and Cats Revenue by Application (2017-2022)
Table 18. Global Antibiotics for Dogs and Cats Revenue Market Share by Application (2017-2022)
Table 19. Global Antibiotics for Dogs and Cats Sale Price by Application (2017-2022) & (US$/Unit)
Table 20. Global Antibiotics for Dogs and Cats Sales by Company (2020-2022) & (K Units)
Table 21. Global Antibiotics for Dogs and Cats Sales Market Share by Company (2020-2022)
Table 22. Global Antibiotics for Dogs and Cats Revenue by Company (2020-2022) ($ Millions)
Table 23. Global Antibiotics for Dogs and Cats Revenue Market Share by Company (2020-2022)
Table 24. Global Antibiotics for Dogs and Cats Sale Price by Company (2020-2022) & (US$/Unit)
Table 25. Key Manufacturers Antibiotics for Dogs and Cats Producing Area Distribution and Sales Area
Table 26. Players Antibiotics for Dogs and Cats Products Offered
Table 27. Antibiotics for Dogs and Cats Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Antibiotics for Dogs and Cats Sales by Geographic Region (2017-2022) & (K Units)
Table 31. Global Antibiotics for Dogs and Cats Sales Market Share Geographic Region (2017-2022)
Table 32. Global Antibiotics for Dogs and Cats Revenue by Geographic Region (2017-2022) & ($ millions)
Table 33. Global Antibiotics for Dogs and Cats Revenue Market Share by Geographic Region (2017-2022)
Table 34. Global Antibiotics for Dogs and Cats Sales by Country/Region (2017-2022) & (K Units)
Table 35. Global Antibiotics for Dogs and Cats Sales Market Share by Country/Region (2017-2022)
Table 36. Global Antibiotics for Dogs and Cats Revenue by Country/Region (2017-2022) & ($ millions)
Table 37. Global Antibiotics for Dogs and Cats Revenue Market Share by Country/Region (2017-2022)
Table 38. Americas Antibiotics for Dogs and Cats Sales by Country (2017-2022) & (K Units)
Table 39. Americas Antibiotics for Dogs and Cats Sales Market Share by Country (2017-2022)
Table 40. Americas Antibiotics for Dogs and Cats Revenue by Country (2017-2022) & ($ Millions)
Table 41. Americas Antibiotics for Dogs and Cats Revenue Market Share by Country (2017-2022)
Table 42. Americas Antibiotics for Dogs and Cats Sales by Type (2017-2022) & (K Units)
Table 43. Americas Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
Table 44. Americas Antibiotics for Dogs and Cats Sales by Application (2017-2022) & (K Units)
Table 45. Americas Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Table 46. APAC Antibiotics for Dogs and Cats Sales by Region (2017-2022) & (K Units)
Table 47. APAC Antibiotics for Dogs and Cats Sales Market Share by Region (2017-2022)
Table 48. APAC Antibiotics for Dogs and Cats Revenue by Region (2017-2022) & ($ Millions)
Table 49. APAC Antibiotics for Dogs and Cats Revenue Market Share by Region (2017-2022)
Table 50. APAC Antibiotics for Dogs and Cats Sales by Type (2017-2022) & (K Units)
Table 51. APAC Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
Table 52. APAC Antibiotics for Dogs and Cats Sales by Application (2017-2022) & (K Units)
Table 53. APAC Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Table 54. Europe Antibiotics for Dogs and Cats Sales by Country (2017-2022) & (K Units)
Table 55. Europe Antibiotics for Dogs and Cats Sales Market Share by Country (2017-2022)
Table 56. Europe Antibiotics for Dogs and Cats Revenue by Country (2017-2022) & ($ Millions)
Table 57. Europe Antibiotics for Dogs and Cats Revenue Market Share by Country (2017-2022)
Table 58. Europe Antibiotics for Dogs and Cats Sales by Type (2017-2022) & (K Units)
Table 59. Europe Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
Table 60. Europe Antibiotics for Dogs and Cats Sales by Application (2017-2022) & (K Units)
Table 61. Europe Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Table 62. Middle East & Africa Antibiotics for Dogs and Cats Sales by Country (2017-2022) & (K Units)
Table 63. Middle East & Africa Antibiotics for Dogs and Cats Sales Market Share by Country (2017-2022)
Table 64. Middle East & Africa Antibiotics for Dogs and Cats Revenue by Country (2017-2022) & ($ Millions)
Table 65. Middle East & Africa Antibiotics for Dogs and Cats Revenue Market Share by Country (2017-2022)
Table 66. Middle East & Africa Antibiotics for Dogs and Cats Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Antibiotics for Dogs and Cats Sales Market Share by Type (2017-2022)
Table 68. Middle East & Africa Antibiotics for Dogs and Cats Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Table 70. Key Market Drivers & Growth Opportunities of Antibiotics for Dogs and Cats
Table 71. Key Market Challenges & Risks of Antibiotics for Dogs and Cats
Table 72. Key Industry Trends of Antibiotics for Dogs and Cats
Table 73. Antibiotics for Dogs and Cats Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Antibiotics for Dogs and Cats Distributors List
Table 76. Antibiotics for Dogs and Cats Customer List
Table 77. Global Antibiotics for Dogs and Cats Sales Forecast by Region (2023-2028) & (K Units)
Table 78. Global Antibiotics for Dogs and Cats Sales Market Forecast by Region
Table 79. Global Antibiotics for Dogs and Cats Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Global Antibiotics for Dogs and Cats Revenue Market Share Forecast by Region (2023-2028)
Table 81. Americas Antibiotics for Dogs and Cats Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Americas Antibiotics for Dogs and Cats Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. APAC Antibiotics for Dogs and Cats Sales Forecast by Region (2023-2028) & (K Units)
Table 84. APAC Antibiotics for Dogs and Cats Revenue Forecast by Region (2023-2028) & ($ millions)
Table 85. Europe Antibiotics for Dogs and Cats Sales Forecast by Country (2023-2028) & (K Units)
Table 86. Europe Antibiotics for Dogs and Cats Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Middle East & Africa Antibiotics for Dogs and Cats Sales Forecast by Country (2023-2028) & (K Units)
Table 88. Middle East & Africa Antibiotics for Dogs and Cats Revenue Forecast by Country (2023-2028) & ($ millions)
Table 89. Global Antibiotics for Dogs and Cats Sales Forecast by Type (2023-2028) & (K Units)
Table 90. Global Antibiotics for Dogs and Cats Sales Market Share Forecast by Type (2023-2028)
Table 91. Global Antibiotics for Dogs and Cats Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 92. Global Antibiotics for Dogs and Cats Revenue Market Share Forecast by Type (2023-2028)
Table 93. Global Antibiotics for Dogs and Cats Sales Forecast by Application (2023-2028) & (K Units)
Table 94. Global Antibiotics for Dogs and Cats Sales Market Share Forecast by Application (2023-2028)
Table 95. Global Antibiotics for Dogs and Cats Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 96. Global Antibiotics for Dogs and Cats Revenue Market Share Forecast by Application (2023-2028)
Table 97. Huvepharma Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 98. Huvepharma Antibiotics for Dogs and Cats Product Offered
Table 99. Huvepharma Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Huvepharma Main Business
Table 101. Huvepharma Latest Developments
Table 102. Merck & Co Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck & Co Antibiotics for Dogs and Cats Product Offered
Table 104. Merck & Co Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Merck & Co Main Business
Table 106. Merck & Co Latest Developments
Table 107. Ceva Animal Health Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 108. Ceva Animal Health Antibiotics for Dogs and Cats Product Offered
Table 109. Ceva Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Ceva Animal Health Main Business
Table 111. Ceva Animal Health Latest Developments
Table 112. Zoetis Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 113. Zoetis Antibiotics for Dogs and Cats Product Offered
Table 114. Zoetis Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Zoetis Main Business
Table 116. Zoetis Latest Developments
Table 117. Crystal Pharma Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 118. Crystal Pharma Antibiotics for Dogs and Cats Product Offered
Table 119. Crystal Pharma Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Crystal Pharma Main Business
Table 121. Crystal Pharma Latest Developments
Table 122. Afrivet Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 123. Afrivet Antibiotics for Dogs and Cats Product Offered
Table 124. Afrivet Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Afrivet Main Business
Table 126. Afrivet Latest Developments
Table 127. Elanco Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 128. Elanco Antibiotics for Dogs and Cats Product Offered
Table 129. Elanco Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Elanco Main Business
Table 131. Elanco Latest Developments
Table 132. Merck Animal Health Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 133. Merck Animal Health Antibiotics for Dogs and Cats Product Offered
Table 134. Merck Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Merck Animal Health Main Business
Table 136. Merck Animal Health Latest Developments
Table 137. Merial Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 138. Merial Antibiotics for Dogs and Cats Product Offered
Table 139. Merial Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Merial Main Business
Table 141. Merial Latest Developments
Table 142. Bayer Animal Health Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 143. Bayer Animal Health Antibiotics for Dogs and Cats Product Offered
Table 144. Bayer Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Bayer Animal Health Main Business
Table 146. Bayer Animal Health Latest Developments
Table 147. Virbac Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 148. Virbac Antibiotics for Dogs and Cats Product Offered
Table 149. Virbac Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Virbac Main Business
Table 151. Virbac Latest Developments
Table 152. Ceva Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 153. Ceva Antibiotics for Dogs and Cats Product Offered
Table 154. Ceva Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Ceva Main Business
Table 156. Ceva Latest Developments
Table 157. Boehringer Ingelheim Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 158. Boehringer Ingelheim Antibiotics for Dogs and Cats Product Offered
Table 159. Boehringer Ingelheim Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Boehringer Ingelheim Main Business
Table 161. Boehringer Ingelheim Latest Developments
Table 162. Vetoquinol Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 163. Vetoquinol Antibiotics for Dogs and Cats Product Offered
Table 164. Vetoquinol Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Vetoquinol Main Business
Table 166. Vetoquinol Latest Developments
Table 167. Phibro Animal Health Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 168. Phibro Animal Health Antibiotics for Dogs and Cats Product Offered
Table 169. Phibro Animal Health Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Phibro Animal Health Main Business
Table 171. Phibro Animal Health Latest Developments
Table 172. NCPC Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 173. NCPC Antibiotics for Dogs and Cats Product Offered
Table 174. NCPC Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. NCPC Main Business
Table 176. NCPC Latest Developments
Table 177. LKPC Basic Information, Antibiotics for Dogs and Cats Manufacturing Base, Sales Area and Its Competitors
Table 178. LKPC Antibiotics for Dogs and Cats Product Offered
Table 179. LKPC Antibiotics for Dogs and Cats Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. LKPC Main Business
Table 181. LKPC Latest Developments

LIST OF FIGURES

Figure 1. Picture of Antibiotics for Dogs and Cats
Figure 2. Antibiotics for Dogs and Cats Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Antibiotics for Dogs and Cats Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Antibiotics for Dogs and Cats Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Antibiotics for Dogs and Cats Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tetracyclines
Figure 10. Product Picture of Penicillins
Figure 11. Product Picture of Sulfonamides
Figure 12. Product Picture of Macrolides
Figure 13. Product Picture of Aminoglycosides
Figure 14. Product Picture of Cephalosporins
Figure 15. Product Picture of Others
Figure 16. Global Antibiotics for Dogs and Cats Sales Market Share by Type in 2021
Figure 17. Global Antibiotics for Dogs and Cats Revenue Market Share by Type (2017-2022)
Figure 18. Antibiotics for Dogs and Cats Consumed in Cats
Figure 19. Global Antibiotics for Dogs and Cats Market: Cats (2017-2022) & (K Units)
Figure 20. Antibiotics for Dogs and Cats Consumed in Dogs
Figure 21. Global Antibiotics for Dogs and Cats Market: Dogs (2017-2022) & (K Units)
Figure 22. Global Antibiotics for Dogs and Cats Sales Market Share by Application (2017-2022)
Figure 23. Global Antibiotics for Dogs and Cats Revenue Market Share by Application in 2021
Figure 24. Antibiotics for Dogs and Cats Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Antibiotics for Dogs and Cats Revenue Market Share by Company in 2021
Figure 26. Global Antibiotics for Dogs and Cats Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Antibiotics for Dogs and Cats Revenue Market Share by Geographic Region in 2021
Figure 28. Global Antibiotics for Dogs and Cats Sales Market Share by Region (2017-2022)
Figure 29. Global Antibiotics for Dogs and Cats Revenue Market Share by Country/Region in 2021
Figure 30. Americas Antibiotics for Dogs and Cats Sales 2017-2022 (K Units)
Figure 31. Americas Antibiotics for Dogs and Cats Revenue 2017-2022 ($ Millions)
Figure 32. APAC Antibiotics for Dogs and Cats Sales 2017-2022 (K Units)
Figure 33. APAC Antibiotics for Dogs and Cats Revenue 2017-2022 ($ Millions)
Figure 34. Europe Antibiotics for Dogs and Cats Sales 2017-2022 (K Units)
Figure 35. Europe Antibiotics for Dogs and Cats Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Antibiotics for Dogs and Cats Sales 2017-2022 (K Units)
Figure 37. Middle East & Africa Antibiotics for Dogs and Cats Revenue 2017-2022 ($ Millions)
Figure 38. Americas Antibiotics for Dogs and Cats Sales Market Share by Country in 2021
Figure 39. Americas Antibiotics for Dogs and Cats Revenue Market Share by Country in 2021
Figure 40. United States Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Antibiotics for Dogs and Cats Sales Market Share by Region in 2021
Figure 45. APAC Antibiotics for Dogs and Cats Revenue Market Share by Regions in 2021
Figure 46. China Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Antibiotics for Dogs and Cats Sales Market Share by Country in 2021
Figure 53. Europe Antibiotics for Dogs and Cats Revenue Market Share by Country in 2021
Figure 54. Germany Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Antibiotics for Dogs and Cats Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Antibiotics for Dogs and Cats Revenue Market Share by Country in 2021
Figure 61. Egypt Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Antibiotics for Dogs and Cats Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Antibiotics for Dogs and Cats in 2021
Figure 67. Manufacturing Process Analysis of Antibiotics for Dogs and Cats
Figure 68. Industry Chain Structure of Antibiotics for Dogs and Cats
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles


More Publications